Sign in

CIK 0001661053

  • Non-accelerated filer
  • Smaller reporting company

enVVeno Medical Corp

Sign in to watch
Ticker
NVNO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330936180
Phone
+1 949-261-2900
Business address
70 DOPPLER, IRVINE, CA, 92618
Former names
Hancock Jaffe Laboratories, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$123
in 1 filing, $123 under 10b5-1 plans

Net −$123. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Duhay Francis −$123 Director sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2025-12-11 Jenusaitis Matthew Director Grant or award · Stock Options +135,883 135,883
2024-12-19 Jenusaitis Matthew Director Purchase +9,620 $2.53 $24K 16,545
2024-12-18 Jenusaitis Matthew Director Grant or award · Stock Options +19,752 19,752
2023-12-05 Jenusaitis Matthew Director Grant or award · Stock Options +13,856 13,856
2022-11-30 Jenusaitis Matthew Director Grant or award · Stock Options +8,403 8,403
2022-09-13 Jenusaitis Matthew Director Exercise or conversion +1,041 6,925
2022-09-13 Jenusaitis Matthew Director Exercise or conversion · Restricted Stock Units −1,041 0
2021-11-30 Jenusaitis Matthew Director Grant or award · Stock Options +7,211 7,211
2021-09-13 Jenusaitis Matthew Director Exercise or conversion +1,042 5,884
2021-09-13 Jenusaitis Matthew Director Exercise or conversion · Restricted Stock Units −1,042 2,084
2021-08-25 Jenusaitis Matthew Director Purchase +1,300 $7.70 $10K 4,842
2021-02-18 Jenusaitis Matthew Director Grant or award · Stock Option +5,673 5,673
2020-07-18 Jenusaitis Matthew Director Grant or award +62,500 62,500
2020-07-18 Jenusaitis Matthew Director Grant or award · Stock Option (Right to Buy) +100,000 100,000
2019-09-13 Jenusaitis Matthew Director Grant or award · Restricted Stock Units +78,125 78,125
2019-09-13 Jenusaitis Matthew Director Grant or award · Stock Option (Right to Buy) +60,000 60,000

Page 1 of 1 · 16 trades